Company news
Theralase Technologies Inc. (TSXV:TLT) news
Theralase Technologies Inc. news releases on 6ix. Latest, Jun 11, 2018: Theralase® Demonstrates Significant Advantage in Treatment of Brain Tumours
Press releases — page 5
Theralase® Demonstrates Significant Advantage in Treatment of Brain Tumours
June 11, 2018
Theralase Demonstrates 36 Months Stability of Lead Anti-Cancer Drug
June 6, 2018
Theralase Release 1Q2018 Financial Statements
May 30, 2018
Theralase Successfully Completes Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study
May 30, 2018
Theralase Provides Update on Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study
May 17, 2018
Theralase Announces Completion of Non-Brokered Private Placement of Units for Aggregate Gross Proceeds of Approximately $1.02 million
May 14, 2018
Theralase Announces Proposed Non-Brokered Private Placement of up to $1 Million
May 8, 2018
Theralase Increases Revenue 22% for 2017 Financial Statements
April 30, 2018
Theralase Provides Update on Phase Ib Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study
April 16, 2018
Theralase Discovers Cannabinoid Increases Efficacy of Patented Anti-Cancer Technology in Destruction of Brain Cancer
March 27, 2018
Theralase Anti-Cancer Technology Effective in Destroying Brain Cancer Stem Cells
March 15, 2018
Rutherrin® Technology Granted Allowance for Canadian Patent
March 7, 2018
Theralase Advances Anti-Cancer Technology in Destruction of Human Lung Cancer
March 5, 2018
Theralase Announces Settlement Agreement with Ontario Securities Commission
February 26, 2018
Theralase Anti-Cancer Technology Treats Sixth Patient for Bladder Cancer
February 9, 2018
Correcting and Replacing: Theralase Anti-Cancer Technology Used to Treat Fifth Patient for Bladder Cancer
January 18, 2018
Theralase Anti-Cancer Technology Used to Treat Fifth Patient for Bladder Cancer
January 18, 2018
Theralase Optimizes Delivery Schedule of Anti-Cancer Vaccine in Destruction of Brain Cancer
January 17, 2018
Theralase Discovers Theralase® Cold Laser Therapy Enhances Cancer Destruction for Standard Cancer Treatments
November 30, 2017
Theralase Increases Revenue 12% for 3Q2017 Financial Statements
November 29, 2017
Theralase Therapeutic Laser Technology Enhances Cancer Destruction
November 27, 2017
Theralase Anti-Cancer Vaccine Validated in Colorectal Cancer
November 22, 2017
Theralase Demonstrates 24 Months Stability of Second Clinical Batch of Lead Anti-Cancer Drug
November 21, 2017
Theralase Discovers New Anti-Cancer Vaccine
November 20, 2017
IIROC Trade Halt - Theralase Technologies Inc.
November 13, 2017
Theralase Researcher Discovers Super Potent Anti-Cancer Drugs
November 13, 2017
Theralase Provides Interim Data Analysis on Anti-Cancer Treatment for First Four Patients Treated
November 8, 2017
Theralase Anti-Cancer Drugs Independently Reviewed
October 31, 2017
Theralase Research to be Presented at International Conference
October 30, 2017
Theralase Lead Anti-Cancer Drug Effective in the Destruction of Brain Cancer when Activated by X-Rays
September 25, 2017
Theralase Lead Anti-Cancer Drug Effective in the Destruction of Throat Cancer
September 19, 2017
Theralase Demonstrates 24 Month Stability of Lead Anti-Cancer Drug
September 18, 2017
Theralase Demonstrates Increased Efficacy for Latest Anti-Cancer Drug
September 12, 2017
Theralase Anti-Cancer Drugs Effective in the Destruction of Cervical Cancer
September 5, 2017
Theralase Increases Revenue 14% for 2Q2017 Financial Statements
August 29, 2017
Theralase Anti-Cancer Drugs Independently Verified and Validated
August 22, 2017
Theralase Anti-Cancer Technology Effective for the Destruction of Lung Cancer
August 8, 2017
Theralase PDT Technology Used to Treat Fourth Patient for Bladder Cancer
August 1, 2017
Theralase Achieves Exploratory Endpoint of Efficacy for Anti-Cancer Technology
July 25, 2017
Theralase Releases Annual and Special Meeting Videos
July 5, 2017
Theralase Provides Clarification Regarding Certain Forward-Looking Statements
June 30, 2017
Theralase Technology Proven Effective for the Treatment of Arthritis
June 29, 2017
Theralase Researcher Granted Second US Patent for Novel Anti-Cancer Drugs
June 26, 2017
Theralase Presents Phosphorescent Photosensitizers at International World Congress
June 15, 2017
Theralase Presents X-Ray Activation at International World Congress
June 14, 2017